Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • JCI vs GSK✓SelectedUSD · GSKJCI vs GSK performance historyLatest closeAs of-4.28%11/20
Stock and ETF performance explorer

JCI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+159.7%
GSK return
+53.4%
Excess return
+106.3%
Maximum drawdown
-21.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.3%-0.1%-4.2%-4.3%
7D-6.6%-5.3%-1.2%-6.3%
30D-13.8%-3.7%-10.1%-13.6%
3M-8.8%-7.3%-1.6%-8.2%
6M-5.0%-4.2%-0.7%-4.9%
YTD+9.7%+0.9%+8.8%+9.7%
1Y+16.2%+7.3%+8.9%+15.4%
3Y+159.7%+52.7%+106.9%+136.4%
All+159.7%+53.4%+106.3%+136.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling